137 related articles for article (PubMed ID: 7929084)
1. Expression of human apolipoprotein B90 in transgenic mice. Demonstration that apolipoprotein B90 lacks the structural requirements to form lipoprotein.
McCormick SP; Linton MF; Hobbs HH; Taylor S; Curtiss LK; Young SG
J Biol Chem; 1994 Sep; 269(39):24284-9. PubMed ID: 7929084
[TBL] [Abstract][Full Text] [Related]
2. Transgenic mice expressing human ApoB95 and ApoB97. Evidence that sequences within the carboxyl-terminal portion of human apoB100 are important for the assembly of lipoprotein.
McCormick SP; Ng JK; Cham CM; Taylor S; Marcovina SM; Segrest JP; Hammer RE; Young SG
J Biol Chem; 1997 Sep; 272(38):23616-22. PubMed ID: 9295301
[TBL] [Abstract][Full Text] [Related]
3. An analysis of the interaction between mouse apolipoprotein B100 and apolipoprotein(a).
Cheesman EJ; Sharp RJ; Zlot CH; Liu CY; Taylor S; Marcovina SM; Young SG; McCormick SP
J Biol Chem; 2000 Sep; 275(36):28195-200. PubMed ID: 10837476
[TBL] [Abstract][Full Text] [Related]
4. Site-specific mutagenesis demonstrates that cysteine 4326 of apolipoprotein B is required for covalent linkage with apolipoprotein (a) in vivo.
Callow MJ; Rubin EM
J Biol Chem; 1995 Oct; 270(41):23914-7. PubMed ID: 7592581
[TBL] [Abstract][Full Text] [Related]
5. Mutation of lysine residues in apolipoprotein B-100 causes defective lipoprotein[a] formation.
Liu CY; Broadhurst R; Marcovina SM; McCormick SP
J Lipid Res; 2004 Jan; 45(1):63-70. PubMed ID: 13130121
[TBL] [Abstract][Full Text] [Related]
6. Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet.
Purcell-Huynh DA; Farese RV; Johnson DF; Flynn LM; Pierotti V; Newland DL; Linton MF; Sanan DA; Young SG
J Clin Invest; 1995 May; 95(5):2246-57. PubMed ID: 7738190
[TBL] [Abstract][Full Text] [Related]
7. Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B-100.
Koschinsky ML; Côté GP; Gabel B; van der Hoek YY
J Biol Chem; 1993 Sep; 268(26):19819-25. PubMed ID: 8366120
[TBL] [Abstract][Full Text] [Related]
8. Antisense oligonucleotide directed to human apolipoprotein B-100 reduces lipoprotein(a) levels and oxidized phospholipids on human apolipoprotein B-100 particles in lipoprotein(a) transgenic mice.
Merki E; Graham MJ; Mullick AE; Miller ER; Crooke RM; Pitas RE; Witztum JL; Tsimikas S
Circulation; 2008 Aug; 118(7):743-53. PubMed ID: 18663084
[TBL] [Abstract][Full Text] [Related]
9. Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice.
Callow MJ; Stoltzfus LJ; Lawn RM; Rubin EM
Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2130-4. PubMed ID: 8134359
[TBL] [Abstract][Full Text] [Related]
10. Mutagenesis of the human apolipoprotein B gene in a yeast artificial chromosome reveals the site of attachment for apolipoprotein(a).
McCormick SP; Ng JK; Taylor S; Flynn LM; Hammer RE; Young SG
Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10147-51. PubMed ID: 7479743
[TBL] [Abstract][Full Text] [Related]
11. Transgenic rabbits expressing human apolipoprotein (a).
Fan J; Watanabe T
J Atheroscler Thromb; 2000; 7(1):8-13. PubMed ID: 11425047
[TBL] [Abstract][Full Text] [Related]
12. Dimyristoylphosphotidylcholine induces conformational changes in apoB that lowers lipoprotein(a).
Wang YT; von Zychlinski A; McCormick SP
J Lipid Res; 2009 May; 50(5):846-53. PubMed ID: 19098283
[TBL] [Abstract][Full Text] [Related]
13. Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits.
Hughes SD; Rouy D; Navaratnam N; Scott J; Rubin EM
Hum Gene Ther; 1996 Jan; 7(1):39-49. PubMed ID: 8825867
[TBL] [Abstract][Full Text] [Related]
14. Characterization and modulation of LP(a) in human hepatoma HEPG2 cells.
Vu H; Cianflone K; Zhang Z; Kalant D; Sniderman AD
Biochim Biophys Acta; 1997 Nov; 1349(2):97-108. PubMed ID: 9421183
[TBL] [Abstract][Full Text] [Related]
15. High-level lipoprotein [a] expression in transgenic mice: evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteins.
Schneider M; Witztum JL; Young SG; Ludwig EH; Miller ER; Tsimikas S; Curtiss LK; Marcovina SM; Taylor JM; Lawn RM; Innerarity TL; Pitas RE
J Lipid Res; 2005 Apr; 46(4):769-78. PubMed ID: 15654123
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein B37, a naturally occurring lipoprotein containing the amino-terminal portion of apolipoprotein B100, does not bind to the apolipoprotein B,E (low density lipoprotein) receptor.
Young SG; Peralta FP; Dubois BW; Curtiss LK; Boyles JK; Witztum JL
J Biol Chem; 1987 Dec; 262(34):16604-11. PubMed ID: 3680266
[TBL] [Abstract][Full Text] [Related]
17. Assembly of lipoprotein (a) in transgenic rabbits expressing human apolipoprotein (a).
Fan J; Araki M; Wu L; Challah M; Shimoyamada H; Lawn RM; Kakuta H; Shikama H; Watanabe T
Biochem Biophys Res Commun; 1999 Feb; 255(3):639-44. PubMed ID: 10049763
[TBL] [Abstract][Full Text] [Related]
18. Carboxyl-terminal truncation of apolipoproteinB-100 inhibits lipoprotein(a) particle formation.
Gabel B; Yao Z; McLeod RS; Young SG; Koschinsky ML
FEBS Lett; 1994 Aug; 350(1):77-81. PubMed ID: 8062928
[TBL] [Abstract][Full Text] [Related]
19. Interaction of apolipoprotein(a) with apolipoprotein B-containing lipoproteins.
Trieu VN; Zioncheck TF; Lawn RM; McConathy WJ
J Biol Chem; 1991 Mar; 266(9):5480-5. PubMed ID: 1848551
[TBL] [Abstract][Full Text] [Related]
20. Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1.
Nakamuta M; Chang BH; Zsigmond E; Kobayashi K; Lei H; Ishida BY; Oka K; Li E; Chan L
J Biol Chem; 1996 Oct; 271(42):25981-8. PubMed ID: 8824235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
